Follistatin vs Noopept
A detailed comparison to help you understand the differences and choose the right peptide for your research goals.
Follistatin
Follistatin is a glycoprotein that inhibits myostatin, the protein responsible for limiting muscle growth. By blocking myostatin, follistatin can theoretically allow for increased muscle development beyond natural limits.
Full details →Noopept
Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) is a peptide-derived nootropic developed in Russia. While technically a dipeptide prodrug rather than a true peptide, it's often discussed alongside peptide nootropics.
Full details →Side-by-Side Comparison
| Aspect | Follistatin | Noopept |
|---|---|---|
| Dose Range | 50 mcg–100 mcg | 10 mg–30 mg |
| Frequency | 1x daily | 2x daily |
| Cycle Length | 2–4 weeks | 4–6 weeks |
| Route | subcutaneous | oral |
| Mechanism | Binds to and neutralizes myostatin and activin, both of which are negative regulators of muscle mass. This removes the natural brake on muscle growth, allowing for enhanced hypertrophy. | Metabolized to cycloprolylglycine which modulates AMPA and NMDA receptors, increases NGF and BDNF expression, and provides neuroprotective effects through antioxidant mechanisms. |
| Typical Dosage | Research protocols typically use 100-300mcg daily, though optimal dosing is not well established. Gene therapy approaches have also been studied. | Oral: 10-30mg daily, typically divided into 2-3 doses. Sublingual use may enhance absorption. Some users go higher but effects may plateau. |
| Administration | Subcutaneous injection. Different isoforms exist (FS344, FS315) with varying properties. Requires careful sourcing due to complexity. | Oral or sublingual administration. Unlike most peptides, it's orally bioavailable. Can be taken with or without food. |
| Side Effects | Limited human data. Theoretical concerns about effects on other organs where activin signaling is important. | Headache (often from choline depletion), irritability, insomnia if taken late, and occasional brain fog during initial use. |
| Best For |
Key Differences
Unique to Follistatin:
Unique to Noopept:
Key Studies
Follistatin
- Heart to Heal: Unveiling Follistatin's Potential for Myocardial Regeneration.
Circulation research, 2025
- Fructose and follistatin potentiate acute MASLD during complete hepatic insulin resistance.
Nature communications, 2025
- Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons.
Science translational medicine, 2024
Noopept
- Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats.
Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2023
- Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats.
International journal of molecular sciences, 2022
- Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process.
Heliyon, 2021
Ready to Learn More?
Looking for trusted sources?